Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.255 USD | -6.49% | -17.79% | +6.56% |
Apr. 01 | Transcript : Yield10 Bioscience, Inc., Q4 2023 Earnings Call, Apr 01, 2024 | |
Apr. 01 | Yield10 Bioscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Chart calendar Yield10 Bioscience, Inc.
Upcoming events on Yield10 Bioscience, Inc.
Past events on Yield10 Bioscience, Inc.
2024-04-01 04:30 pm | Q4 2023 Earnings Call |
2024-04-01 04:01 pm | Q4 2023 Earnings Release |
2023-11-14 04:30 pm | Q3 2023 Earnings Call |
2023-11-14 04:01 pm | Q3 2023 Earnings Release |
2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
2023-08-14 04:30 pm | Q2 2023 Earnings Call |
2023-08-14 04:01 pm | Q2 2023 Earnings Release |
2023-05-25 10:00 am | Annual General Meeting |
2023-05-24 | Annual General Meeting |
2023-05-10 04:30 pm | Q1 2023 Earnings Call |
2023-05-10 04:02 pm | Q1 2023 Earnings Release |
2023-05-01 | AOCS Meeting |
2023-03-22 | ABLC Conference |
2023-03-14 04:30 pm | Q4 2022 Earnings Call |
2023-03-14 04:02 pm | Q4 2022 Earnings Release |
2023-02-21 01:30 pm | Winter Wonderland Best Ideas Investor Conference - Panel |
2022-12-01 01:30 pm | Canaccord Genuity CG AgriFood Tech Innovation Virtual Forum |
2022-11-14 04:30 pm | Q3 2022 Earnings Call |
2022-11-14 04:02 pm | Q3 2022 Earnings Release |
2022-10-12 04:30 pm | MicroCap Rodeo The Windy City Roundup Investor Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,81 0,86 -6.6% | 0,80 0,86 -6.77% | 0,61 0,56 9.74% | 0,45 0,49 -7.79% | 0,06 0,06 0% | 2,25 |
EBITDA Million USD | Released Forecast Spread | -8,39 -7,81 -7.42% | -9,43 -9,03 -4.4% | -11,5 -11,7 1.81% | -13,2 -13,5 2.1% | -14,1 -14,5 2.4% | -11,3 |
EBIT Million USD | Released Forecast Spread | -8,60 -8,37 -2.72% | -9,61 -9,23 -4.08% | -11,7 -11,9 1.68% | -13,5 -13,7 1.96% | -14,4 -14,8 2.34% | -11,7 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,2 -8,29 -59.37% | -10,2 -9,71 -4.54% | -11,0 -11,9 7.32% | -13,4 -13,7 1.87% | -14,5 -14,9 2.82% | -13,5 |
Net income Million USD | Released Forecast Spread | -13,0 -8,29 -56.3% | -10,2 -9,78 -4.38% | -11,0 -11,6 4.52% | -13,6 -13,7 1.25% | -14,5 -14,8 2.33% | -11,7 |
EPS USD | Released Forecast Spread | -35,5 -24,2 -46.69% | -4,30 -4,43 2.86% | -2,33 -2,36 1.27% | -2,76 -2,68 -2.99% | -1,82 -2,00 8.77% | -0,76 |
Announcement Date | 19/03/20 | 16/03/21 | 09/03/22 | 14/03/23 | 01/04/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,15 0,10 55.9% | 0,15 0,17 -13.87% | 0,10 0,16 -35.32% | 0,11 0,13 -16.54% | 0,09 0,13 -30.4% | 0,06 0,07 -18.18% | 0,00 0,03 - | 0,00 0,08 - | 0,00 0,00 - | 1,88 | 0,38 | 0,00 | 0,00 | 0,00 |
EBITDA Million USD | Released Forecast Spread | -2,91 -3,12 6.75% | -3,26 -3,14 -3.74% | -3,37 -3,37 0.16% | -3,42 -3,44 0.43% | -3,14 -3,42 8.26% | -3,73 -3,55 -5.16% | -3,59 -3,71 3.31% | -3,63 -3,62 -0.22% | -3,17 -3,52 9.88% | -1,55 | -2,83 | -3,46 | -3,47 | |
EBIT Million USD | Released Forecast Spread | -2,97 -3,17 6.3% | -3,32 -3,19 -3.96% | -3,44 -3,43 -0.28% | -3,49 -3,49 0.1% | -3,20 -3,47 7.75% | -3,80 -3,60 -5.46% | -3,67 -3,78 3.02% | -3,70 -3,69 -0.35% | -3,25 -3,59 9.62% | -1,65 | -2,93 | -3,56 | -3,57 | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,97 -3,14 5.36% | -3,32 -3,13 -6.1% | -3,43 -3,37 -1.84% | -3,48 -3,41 -1.93% | -3,17 -3,43 7.33% | -3,78 -3,47 -8.85% | -3,68 -3,72 0.96% | -3,73 -3,66 -1.8% | -3,27 -3,65 10.52% | -2,00 | -3,50 | -4,00 | -4,00 | |
Net income Million USD | Released Forecast Spread | -2,98 -3,15 5.47% | -3,33 -3,19 -4.52% | -3,44 -3,42 -0.69% | -3,49 -3,49 -0.11% | -3,30 -3,47 4.89% | -3,78 -3,59 -5.33% | -3,68 -3,77 2.33% | -3,73 -3,68 -1.31% | -3,27 -3,59 9.09% | -1,65 | -2,93 | -3,56 | -3,57 | |
EPS USD | Released Forecast Spread | -0,61 -0,64 3.94% | -0,68 -0,65 -4.21% | -0,70 -0,69 -1.45% | -0,71 -0,66 -7.17% | -0,67 -0,61 -10.74% | -0,76 -0,63 -20% | -0,64 -0,54 -17.79% | -0,41 -0,39 -4.24% | -0,12 -0,31 60.66% | -0,11 | -0,19 | -0,23 | -0,23 | -0,26 |
Announcement Date | 09/03/22 | 11/05/22 | 10/08/22 | 14/11/22 | 14/03/23 | 10/05/23 | 14/08/23 | 14/11/23 | 01/04/24 | - | - | - | - | - |
Past sector events for Yield10 Bioscience, Inc.
2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- YTEN Stock
- Calendar Yield10 Bioscience, Inc.